-transparent.png){kind=logo}
75 outpatients who presented to an affective disorder clinic received the dexamethasone suppression test (DST). Following 1 week observation, and following 1 week on low-dose imipramine HCl, all patients who remained depressed (Hamilton score 16 or greater) were given a full clinical trial of imipramine HCl (150-300 mg/day) over a minimum 3- to 5-week period. Of the 45 patients who required this trial and who received imipramine HCl for at least 3 weeks, there was no relationship between DST suppression or nonsuppression vs. clinical response to imipramine HCl. There was a statistically significant trend for suppressors (negative DST) to respond either spontaneously or to low-dose imipramine HCl as opposed to nonsuppressors (positive DST).
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
November 1982,
The New England journal of medicine,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
October 1992,
Journal of intellectual disability research : JIDR,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
September 1981,
The American journal of psychiatry,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
July 1983,
The American journal of psychiatry,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
September 1984,
The Journal of clinical psychiatry,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
April 1983,
The American journal of psychiatry,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
December 1989,
The Journal of nervous and mental disease,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
January 1986,
Journal of affective disorders,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
May 1988,
The British journal of psychiatry : the journal of mental science,
E D Peselow, and
N Goldring, and
F Barouche, and
R R Fieve
May 1987,
The Journal of clinical psychiatry,
